Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The Lancet. Global Health
|
May 13, 2022
The future is urban: integrated planning policies can enable healthy and sustainable cities
Deepti Adlakha, Felix John
Innere Medizin (Heidelberg, Germany)
|
October 17, 2025
[Treatment of metastatic non-small cell lung cancer]
Malte Verheyen, Lea Ruge, Felix John, et al.
Innere Medizin (Heidelberg, Germany)
|
February 8, 2024
[Advances in the targeted treatment of non-small cell lung cancer]
Lea Ruge, Felix John, Heather Scharpenseel, et al.
Frontiers in Oncology
|
April 17, 2026
Global disparities in access to diagnostics and therapies for advanced non-small cell lung cancer: from discovery to delivery - a review
Lea Ruge, Malte Verheyen, Felix John, et al.
Molecular Neurobiology
|
March 18, 2018
Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation
Pascal Röderer, Lara Klatt, Felix John, et al.
Frontiers in Cellular Neuroscience
|
September 19, 2022
ROS scavengers decrease γH2ax spots in motor neuronal nuclei of ALS model mice <i>in vitro</i>
Maya Junghans, Felix John, Hilal Cihankaya, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 30, 2025
Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort
Matthias Scheffler, Lia Tzala, Karly Louie, et al.
JTO Clinical and Research Reports
|
March 12, 2026
MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET Inhibition
Richard Riedel, Lea Ruge, Malte Verheyen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 14, 2023
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients
Moritz Glaser, Anna Rasokat, Darinka Prang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2026
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses
Lea Ruge, Felix John, Malte Verheyen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The Lancet. Global Health
|
May 13, 2022
The future is urban: integrated planning policies can enable healthy and sustainable cities
Deepti Adlakha, Felix John
Innere Medizin (Heidelberg, Germany)
|
October 17, 2025
[Treatment of metastatic non-small cell lung cancer]
Malte Verheyen, Lea Ruge, Felix John, et al.
Innere Medizin (Heidelberg, Germany)
|
February 8, 2024
[Advances in the targeted treatment of non-small cell lung cancer]
Lea Ruge, Felix John, Heather Scharpenseel, et al.
Frontiers in Oncology
|
April 17, 2026
Global disparities in access to diagnostics and therapies for advanced non-small cell lung cancer: from discovery to delivery - a review
Lea Ruge, Malte Verheyen, Felix John, et al.
Molecular Neurobiology
|
March 18, 2018
Increased ROS Level in Spinal Cord of Wobbler Mice due to Nmnat2 Downregulation
Pascal Röderer, Lara Klatt, Felix John, et al.
Frontiers in Cellular Neuroscience
|
September 19, 2022
ROS scavengers decrease γH2ax spots in motor neuronal nuclei of ALS model mice <i>in vitro</i>
Maya Junghans, Felix John, Hilal Cihankaya, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 30, 2025
Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort
Matthias Scheffler, Lia Tzala, Karly Louie, et al.
JTO Clinical and Research Reports
|
March 12, 2026
MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET Inhibition
Richard Riedel, Lea Ruge, Malte Verheyen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 14, 2023
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients
Moritz Glaser, Anna Rasokat, Darinka Prang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 10, 2026
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses
Lea Ruge, Felix John, Malte Verheyen, et al.
Page
of 2